Article Text

Download PDFPDF
Splenic marginal zone lymphoma with predominant red pulp involvement lacking p53 overexpression
  1. S-S Chuang1,
  2. C-F Li2,
  3. D Lu3,
  4. T-C Tsai4,
  5. C-J Tsao5
  1. 1Department of Pathology, Chi-Mei Medical Centre, Tainan; Taipei Medical University, Taipei, Taiwan
  2. 2Department of Pathology, Chi-Mei Medical Centre, Tainan, Taiwan
  3. 3Department of Pathology, Liou-ying Chi-Mei Hospital, Tainan, Taiwan
  4. 4Department of Surgery, Liou-ying Chi-Mei Hospital, Tainan, Taiwan
  5. 5Department of Internal Medicine, Liou-ying Chi-Mei Hospital, Tainan, Taiwan
  1. Correspondence to:
    S-S Chuang
    Department of Pathology, Chi-Mei Medical Center, 901 Chung-Hwa Road, Yung-Kang City, Tainan County 710, Taiwan; cmh5301{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Splenic marginal zone lymphoma (SMZL) is defined in the World Health Organization (WHO) classification as a B cell lymphoma comprising small lymphocytes that surround and replace the splenic white pulp and merge with a peripheral (marginal) zone of larger cells, leading to a biphasic zonal pattern. The tumour involves the spleen, splenic hilar lymph node, bone marrow and often, peripheral blood. Recently, Mollejo et al1 proposed a putative diffuse variant of SMZL with predominantly red-pulp involvement, absence of follicular replacement and a monomorphous population of tumour cells resembling marginal zone B cells, with scattered nucleolated blast cells. They found high p53 expression in all four patients, with p53 gene mutation in two.

Here, we report a case similar to that reported by Mollejo et al, without p53 overexpression. A 34-year-old woman presented …

View Full Text


  • Competing interests: None declared.